Keyphrases
Age at Diagnosis
12%
Age Groups
25%
Allogeneic
12%
Autologous SCT
12%
Autologous Stem Cell Rescue
12%
Busulphan
25%
Europe
100%
Event-free Survival
12%
First Remission
25%
High Risk
12%
High-dose Therapy
100%
Marrow Transplantation
12%
Melphalan
50%
Multivariate Analysis
12%
Neuroblastoma
100%
Partial Remission
12%
Peripheral Stem Cells
12%
Randomized Trial
12%
Remission Status
25%
Sensitive Relapse
12%
Single High Dose
12%
Stable Disease
12%
Young Patients
12%
Nursing and Health Professions
Busulfan
25%
Diseases
12%
Drug Megadose
100%
Event Free Survival
12%
Melphalan
50%
Multivariate Analysis
12%
Neuroblastoma
100%
Patient with Neuroblastoma
12%
Remission
62%
Pharmacology, Toxicology and Pharmaceutical Science
Busulfan
40%
Diseases
20%
Event Free Survival
20%
Melphalan
80%
Neuroblastoma
100%
Remission
100%
Medicine and Dentistry
Busulfan
25%
Diseases
12%
Drug Megadose
100%
Event Free Survival
12%
Ganglioneuroblastoma
100%
Melphalan
50%
Multivariate Analysis
12%
Patient with Neuroblastoma
12%
Stem Cell
25%
Agricultural and Biological Sciences
Multivariate Analysis
50%
Progenitor Cell
100%